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Caesarean section delivery (CSD) disrupts mother-to-neonate transmission of specific microbial strains and functional repertoires as
well as linked immune system priming. Here we investigate whether differences in microbiome composition and impacts on host
physiology persist at 1 year of age. We perform high-resolution, quantitative metagenomic analyses of the gut microbiomes of
infants born by vaginal delivery (VD) or by CSD, from immediately after birth through to 1 year of life. Several microbial populations
show distinct enrichments in CSD-born infants at 1 year of age including strains of Bacteroides caccae, Bifidobacterium bifidum and
Ruminococcus gnavus, whereas others are present at higher levels in the VD group including Faecalibacterium prausnitizii,
Bifidobacterium breve and Bifidobacterium kashiwanohense. The stimulation of healthy donor-derived primary human immune cells
with LPS isolated from neonatal stool samples results in higher levels of tumour necrosis factor alpha (TNF-α) in the case of CSD
extracts over time, compared to extracts from VD infants for which no such changes were observed during the first year of life.
Functional analyses of the VD metagenomes at 1 year of age demonstrate a significant increase in the biosynthesis of the natural
antibiotics, carbapenem and phenazine. Concurrently, we find antimicrobial resistance (AMR) genes against several classes of
antibiotics in both VD and CSD. The abundance of AMR genes against synthetic (including semi-synthetic) agents such as phenicol,
pleuromutilin and diaminopyrimidine are increased in CSD children at day 5 after birth. In addition, we find that mobile genetic
elements, including phages, encode AMR genes such as glycopeptide, diaminopyrimidine and multidrug resistance genes. Our
results demonstrate persistent effects at 1 year of life resulting from birth mode-dependent differences in earliest gut microbiome
colonisation.
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INTRODUCTION
The rate of caesarean section delivery is constantly increasing
worldwide, which is partly driven by increases in overall income
and access to health facilities.1 According to a 2015 report, 29.7
million births occurred via CSD in that year accounting for ~18%
of the births in 169 countries.1 At 25% in Europe, this number is
higher than the global average.2 The short-term risks of CSD
include delayed or altered development of the immune system,3
reduced gut microbiome diversity,4 limited transmission of
bacterial strains from mother to neonate5,6 and microbiome-
borne functional deficiencies.7–10 Although few studies associate
CSD with metabolic disorders11,12 and allergies,13,14 the long-term
effects of birth mode are not well understood. Shao et al. reported
that CSD may predispose individuals to colonisation by opportu-
nistic pathogens including those carrying antimicrobial resistance
(AMR) genes.15 On the one hand, several reports including our
previously published study8 addressed questions concerning the
very early development of the neonate’s gut microbiomes14,16 and
immune system priming3 in relation to disease development.17,18
On the other hand, only few reports19–22 follow the effects of birth
mode during the first year of life especially in relation to immune
system priming, development and evolution of AMR, and the
contribution of mobile genetic elements to the persistence of
AMR genes.
Factors including environmental exposure,14 breast feeding and
diet19,23,24 and genetics25 play crucial roles in the development of
an infant. Aside from this, it is now generally accepted that birth
mode, i.e. vaginal delivery (VD) or CSD, has a pronounced impact
on early microbiome structure.3,8,11,26,27 While the majority of
these studies focus on overall microbiome structure, analyses of
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the functional contribution of the microbiome has attracted
attention due to its sensitivity to perturbation.28 For example, we
previously reported that the microbiome in VD-born babies was
enriched in bacterial genes encoding for lipopolysaccharide (LPS)
biosynthesis, cationic antimicrobial peptide resistance as well as
two-component systems.8 Interestingly, higher levels of LPS
biosynthesis genes were associated with increased immune
responses in VD neonates, whereas CSD neonates had reduced
levels of TNF-α and IL-18 immediately after birth. Noteworthy in
this context is previous work by Vatanen et al. which showed that
differing LPS immunogenicity contributes to autoimmunity
thereby affecting the long-term health outcomes of infants
exposed to different antigens.29 Furthermore, others have
hypothesized and reported3,30 a similar phenomenon, whereby
the gut microbiome contributes to the development of the
immune system during a “critical window” of development.3,30–36
In a neonatal cohort at risk for the development of asthma,
bacterial metabolites were shown to specifically impede immune
tolerance.37 However, some of the reports described above do not
elaborate on the continuous effect of early immune system
priming in the context of the birth mode and especially over the
course of the first year of life, including whether these effects
normalize over time.
Aside from the well-studied factors and consequences of
development described above, the role of commensal microbiota
in the emergence and spread of AMR is not well understood.
Recent studies have reported that antibiotic exposure in infancy
affects microbial diversity, and enriches AMR genes. Interestingly,
Ravi et al. have suggested that the infant gut microbiome acts as a
reservoir for multidrug resistance that persists throughout infancy
up to 2 years of age.38 They reported that integrons (int1 gene) in
the gut could potentially be responsible for this phenomenon.
Nevertheless, the effect of birth mode, CSD or VD, on the
transmission and occurrence of AMR remains unresolved.
Here, we address the aforementioned gaps in knowledge
concerning the effect of birth mode on the persistence of the gut
microbiota over the first year of life including their inherent
functions, immunogenic properties and their role in conferring
AMR. Our results highlight birth mode-dependent differences in
gut microbiome structure and their association with immune
function. We found that the gut microbiota becomes similar
between CSD and VD babies at 1 year of age, with the exception
of an immunostimulatory commensal, Faecalibacterium prausnitzii,
which was enriched in the VD group. In addition, we identified an
increased abundance in AMR genes directed against synthetic and
semi-synthetic antibiotics in CSD as early as 5 days postpartum.
Strikingly, we found that mobile genetic elements (MGEs)
including plasmids and bacteriophages are key contributors to
the establishment and persistence of AMR, irrespective of birth
mode. Collectively, our findings suggest that birth mode-
dependent effects persist through the first year of life including
the delayed immunostimulation of CSD infants likely affecting
tolerance mechanisms as well as the apparent role of bacter-
iophages in conferring AMR.
RESULTS
Birth mode-dependent gut microbiota differences during the
first year
We previously described the initial seeding and colonisation
processes within the human gut microbiome and identified
differences in microbiome structure and function as well as linked
immunogenicity and immune system priming, which stratified
according to birth mode.8,39 Building on this work, we aimed to
understand the long-term effects in relation to the observed
differences, especially through the first year of life which
represents a “critical window” of development including physio-
logical growth and immune system maturation. To achieve this,
we followed VD and CSD neonates in our cohort and collected
faecal samples at crucial intervals after birth, including 5 days,
1 month, 6 months and at 1 year of age (Fig. 1a). In one of our
previous studies,8 a multivariate analysis was performed to
compare the profiles of CSD (±SGA) to VD neonates. The results
of these analyses demonstrated that delivery mode was the
strongest determining factor in the microbial profile and predicted
functions, irrespective of the infants were born SGA or not.8 In
light of these analyses, we included the SGA samples within the
CSD group. We reconstructed microbial genomes and identified
differentially abundant taxa and functions between the groups
using metagenomic sequencing data. Based on metagenomic
operational taxonomic units (mOTUs), we calculated the
Jensen–Shannon divergence index and found that the intra-
group variability within CSD or VD was minimal while the inter-
group variability between CSD and VD groups was significantly
different (Supplementary Fig. 1). At the genus level, our data also
recapitulated previously described8 significantly increased levels
of Bacteroides (FDR-adjusted p < 0.05, Wilcoxon rank-sum test) in
the VD neonates compared to CSD at the early timepoints (day 5
after birth and at 1 month). B. caccae also showed an increasing
trend in the CSD group at 6 months and after 1 year of age, while
B. caecimuris was significantly increased in CSD at 5 days after
birth (Fig. 1b; FDR-adjusted p < 0.05, Wilcoxon rank-sum test) and
showed an increasing trend at 1 year of age. However, at 1 year of
age, the abundance of this genus in samples from CSD neonates
was comparable to the levels in the VD group. In contrast, the
levels of Bifidobacterium were increased in VD after 6 months,
while Faecalibacterium prausnitzii, a commensal associated with
healthy human microbiomes,40 was found to be significantly
increased in the VD group at 1 year of age (Fig. 1b, FDR-adjusted p
< 0.05, Wilcoxon rank-sum test). We further found that both birth
mode and the neonatal age affect the gut microbiome community
structure, whereby the latter contributes highly to variation within
and between the groups (Fig. 1c). The taxonomic profiles at 1 year
of age were distinct when compared to day 5, 1 month and
6 months from both groups.
Assessment of differences in metagenomic functional
potential at 1 year of age
Taxonomic differences within the gut microbiome populations
may not always manifest as differences in functional diversity due
to the redundancy in the latter. To address this, we assigned
KEGG41 orthology identifiers (KOs) to each gene identified from
both groups. We found 84 differentially abundant KOs between
VD and CSD samples at 1 year of age (Fig. 2a). In addition, we
linked all identified KOs (n= 7103) to their corresponding KEGG
orthology pathways (Fig. 2b) and performed differential pathway
analyses. We found that the VD group showed an increase in the
gene copy numbers of pathways involved in carbapenem and
phenazine biosyntheses (Fig. 2c). We found that 21 unique genera
were associated with carbapenem biosynthesis across both
groups (Supplementary Data 1) spanning all major phyla found
within the gut.
Pro-inflammatory immune responses elevated in CSD after 1
year of life
In the early stages of neonatal development, we found that the
immune activation potential of LPS was significantly increased in
samples from VD neonates,8 whereby the isolated LPS triggered
the secretion of TNF-α and IL-18 by monocyte-derived dendritic
cells (MoDCs) from four healthy adult donors. To determine if the
immunostimulatory potential persisted at 1 year of age, we
stimulated the MoDCs (obtained from four healthy adult donors)
with LPS isolated from the faecal samples of the CSD and VD
groups. In addition to TNF-α and IL-18, we also tested the
potential of LPS to stimulate secretion of pro- and anti-
inflammatory cytokines such as IL-1ß, IL-12, IL-8 and IL-10 (Fig.
S.B. Busi et al.
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Fig. 1 Gut microbiome profiles throughout the first year of life. aWorkflow representation of DNA and LPS isolation from faecal samples for
metagenomic, immune and functional AMR analyses. b Relative abundances of metagenomic operational taxonomic units (mOTUs) >1%
abundance at day 5 after birth, 1 month, 6 months, and at 1 year of age. c Canonical correlation analyses (CCA) resolving the stratification of
taxonomic profiles based on two covariates, i.e. birth mode and time when samples were sequenced.
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3a). Interestingly, at 1 year of age, IL-18 was below the detection
limits. We did not find any significant differences between the CSD
and VD groups with respect to the levels of secreted TNF-α at 1
year of age. However, contrary to the patterns observed at 5 days
after birth, we found that the levels of TNF-α stimulated by LPS
were significantly increased at 1 year of age within the CSD group
(p < 3.5 × 10−5, paired two-way ANOVA; Fig. 3b). Interestingly, the
increase in stimulated TNF-α levels in CSD at 1 year of age was
similar to the level of the cytokine stimulated by LPS from the day
5 VD samples (Fig. 3b). In addition, we found that the stimulated
TNF-α levels at 1 year of age were positively correlated with the
abundance of several mOTUs, including Bacteroides caecimuris and
Haemophilus influenzae (Fig. 3c). Previous reports42 suggest that
Enterobacteriaceae levels correlate with inflammatory levels.
However, we did not find a correlation of these taxa with LPS
levels in our study (Supplementary Fig. 2). Our data also indicate
an increase in the number of Gram-negative (G-ve) bacteria at 1
year of age compared to day 5 after birth in the CSD group
(Supplementary Fig. 3). The increase in Shannon diversity at 1 year
of age compared to day 5 coupled with the increase in G-ve
bacteria provides a mechanistic explanation why the LPS
stimulation of donor cells from faecal samples of CSD resulted
in similar levels of TNF-α (Fig. 3b), as observed with faecal samples
from the VD group at 1 year of age.
Antimicrobial resistance modulated by birth mode
The analyses of the functional potential based on KEGG orthology
revealed a stratification of antibiotic biosynthesis pathways based
on whether an infant was born by CSD or VD (Fig. 2c). To assess
and validate the impact of birth mode on the presence and
persistence of AMR, we used a deep-learning approach43 to
annotate antibiotic resistance genes in our metagenomic data.44
We determined the presence and relative abundance of AMR
genes in samples collected from both CSD and VD at day 5 after
birth, 1 month, 6 months and at 1 year of age. The samples
collected from CSD neonates exhibited an increased abundance in
AMR genes at the earliest time point (day 5) compared to the VD
group. In addition, we found that the number of AMR genes
detected in CSD infants at 1 year of age was significantly reduced
in comparison to the CSD samples at day 5 (FDR-adjusted p <
0.0021, Wilcoxon rank-sum test; Fig. 4a, Supplementary Fig. 4a). To
corroborate our observations on the levels of AMR genes, we
assessed the abundance of AMR genes using a random subset of
samples from the resistome study by Gasparrini et al.45 We found
that the overall levels of AMR genes starting at 1 month through
to 1 year of age were similar in their study to those observed in
our own cohort (Supplementary Fig. 4b). Meanwhile in our study,
at 1 year of age, we found several genes that were differentially
abundant between the CSD and VD groups (FDR-adjusted p <
0.05, Wilcoxon rank-sum test; Fig. 4b). Since various genes can
confer resistance to the same antibiotic, we regrouped the genes
into their respective categories such as multidrug, tetracycline
resistance etc. We found that genes conferring glycopeptide,
phenicol, pleuromutilin, bacitracin, sulfonamide and diaminopyr-
imidine resistance were significantly increased in CSD compared
to VD at day 5 after birth (Fig. 4c, Supplementary Fig. 5; FDR-
adjusted p < 0.05, Wilcoxon rank-sum test). Interestingly, diamino-
pyrimidine, phenicol, pleuromutilin, and sulfonamide are synthetic
or semi-synthetic antibiotics and, likely prevalent in the hospital
environment.46–49 However, these differences did not persist
Fig. 2 Functional differences at 1 year of age. a Volcano plot
depicting the statistically significantly different KEGG orthologs
found in both CSD and VD groups at 1 year of age. A total of 6413
variables were tested, with −log10(p-value) shown on the y-axis.
Green dots indicate KOs with a fold change >2. Red dots indicate
KOs with a significant fold-change cut-off of 2, and with a false-
discovery rate-adjusted p-value cut-off of 0.01. b Heatmap based on
the KEGG pathways found in both CSD and VD samples at 1 year of
age. Each row denotes a pathway represented by the KO genes, with
the hierarchical clustering being based on Euclidean distances using
Ward’s clustering algorithm. c Volcano plot of the 219 KEGG
pathways to which the KOs were mapped, tested for significance
with a fold-change cut-off of 2, and with a false-discovery rate-
adjusted p-value cut-off of 0.01. The insets show carbapenem and
phenazine biosynthesis pathways that were statically significantly
different. ***p-value < 0.001.
S.B. Busi et al.
4
ISME Communications             (2021) 1:8 
over time. In addition, the mothers in our cohort across both
groups (CSD:6 and VD:1) received prophylactic treatment against
group B Streptococcus (Supplementary Data 2) in the form of
cephalosporin. However, we did not find any distinguishing
patterns within the resistance categories corresponding to this
treatment regimen. Albeit a limited sample size, we also tracked
the diet including feeding method (bottle- or breast-fed),
antibiotic regimen and physical characteristics through the first
year and did not find any significant correlations with functional























































































































































































































































































































































































































































































































































































































































































Fig. 3 Immunostimulatory potential at 1 year of age. a Heatmap
depicting the abundance (log2) of pro- and anti-inflammatory
cytokines at 1 year of age. Cytokine levels were measured by
stimulating MoDCs from healthy donors (Donor 1–4) with LPS
isolated from faecal samples of CSD and VD neonates. b Boxplots
depicting the TNF-α levels in both groups (CSD and VD) at day 5
after birth and 1 year of age. Paired two-way ANOVA (analysis of
variance) p-values are listed in the plot to depict significant
differences. ***p-value < 0.001. c Correlation of TNF-α levels (row 1)
with the relative abundance of metagenomic OTUs based on
canonical correlation analysis. Filled squares indicate significantly
correlated taxa, whereas colour indicates positive (red) or negative
(blue) correlation.
Fig. 4 Antimicrobial resistance gene abundances over time. a
Boxplots of the overall AMR gene abundance in CSD and VD
samples at different timepoints including 5 days after birth and at 1
year of age. Wilcoxon rank-sum tests were used to test for
significance. *p < 0.05. b Volcano plot depicting the significantly
enriched genes in either CSD or VD samples at 1 year of age. c AMR
categories which are significantly different between the groups at
any of the timepoints are shown. Wilcoxon rank-sum tests were
used to test for significance. *p < 0.05.
S.B. Busi et al.
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Taxa associated with antimicrobial resistance
Since AMR genes were found in the metagenomic data, we
investigated which taxa carried these genes by reconstructing
metagenome-assembled genomes (MAGs), classifying them tax-
onomically based on the GTDB database,50 and linking AMR
genes to individual MAGs. We then compared taxa contributing
to AMR between birth mode at day 5 after birth and 1 year of
age as well as the change over time within the individual groups
(Fig. 5a).
Comparing CSD with VD, we found that shortly after birth, i.e. at
day 5, Bacilli contributing to AMR were enriched in CSD, while
Bifidobacteriaceae, Bacteroidales, Eggerthellaceae, and Actinobac-
teria linked to AMR were more abundant in VD samples. At 1 year
of age, other taxa including Burkholderiaceae, Ruminococcaceae
and Bacteroidales were prevalent in CSD samples (Fig. 5a). In
contrast, taxa including Enterobacteriales were enriched in VD
compared to CSD at 1 year of age.
We compared samples from day 5 after birth versus 1 year of
age within each birth mode group independently to differentiate
between taxonomic groups contributing to AMR. Within CSD
samples, we found that Enterobacteriales and Staphylococcaceae
were enriched at day 5 after birth while major AMR contributors at
1 year of age were Lachnospiraceae, Bacteroidaceae, Actinobacteria
and Oscillospirales. Conversely, within VD samples early AMR
resistance was mainly attributed to the abundance of Bacteroi-
dales, Lactobacillales, Propionibacteraceae and Enterobacteriaceae
at day 5 after birth. Meanwhile, at 1 year of age, VD samples were
enriched in taxa including Lachnospiraceae, Ruminococcaceae,
Veillonellales and Eggerthellaceae with respect to contribution of
AMR genes to the resistome (Fig. 5a). These data suggest that AMR
genes are also encoded by commensals apart from pathogens
which, in the context of the present study, sustain their presence
throughout the first year of life.
Role of mobile genetic elements in antimicrobial resistance
Bacterial genomes have been fine-tuned over evolutionary
timescales,51 potentially refining their defence mechanisms
against various biocidal agents including chemicals. Aside from
these, bacterial components such as MGEs are known to be potent
factors in the spread of AMR52 and can transfer genes across
distinct taxonomic clades. An example of such MGEs are plasmids
as well as viruses including bacteriophages, which actively drive
the transfer of genetic material.53 To determine the role of MGEs
in conferring AMR in our neonate cohort, we analysed the
genomic context of the AMR genes. The contigs were classified as
chromosomal, plasmid, phage, ambiguous (those that could not
be resolved) and unclassified. In this study, chromosomal
sequences refer to the bacterial genome excluding plasmids, in
accordance with the PlasFlow54 methodology. These criteria were
used to assess the role of MGEs at all timepoints. The majority
(average of ~75%) of the AMR genes were encoded on the
bacterial chromosome (Fig. 5b). This phenomenon was prominent
in the VD samples irrespective of sampling time point. On the
other hand, the mean relative abundance of AMR genes encoded
on plasmids (~5%) was marginally increased in the CSD group at
both 5 days after birth and at 1 year of age. Overall, we found that
phages encoded lower levels (1–3%) of AMR genes compared to
the plasmids. However, we found that the relative abundances of
phages encoding AMR were significantly increased after 1 year of
age (Fig. 5b). Interestingly, we did not find any significant
Fig. 5 Taxa and mobile genetic elements associated with
antimicrobial resistance. a Tree plots depicting the median
proportion of AMR-associated taxa at day 5 after birth and at 1
year of age comparing the CSD and VD groups. Values used for
plotting the trees are an average of all the samples within the group.
b The relative abundances of AMR genes found on the bacterial
chromosome, plasmids or phages at the different timepoints,
ranging from day 5 after birth through to 1 year of age. CSD=
blue (left panel), VD= green (right panel). Paired two-way ANOVA
was used to assess significant differences; adjusted p-values are
shown in the plot to depict significant differences. *p-value < 0.05. c
Stacked bar plot depicting the AMR categories transmitted via
phages and plasmids at all timepoints. Each colour in the plot is
associated with a category listed in the legend on the right. The plot
represents mean values for all samples in each group.
S.B. Busi et al.
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differences between the birth modes in relation to the virome
profiles at any of the timepoints (FDR-adjusted p > 0.05, two-way
ANOVA, Supplementary Fig. 7). However, a large proportion of the
contigs were either ambiguous or unclassified but demonstrated
an even distribution across all timepoints (Supplementary Fig. 8a).
When ambiguous sequences mapping to both the bacterial
chromosome and phages are included in the phage abundance
metrics, it results in a higher abundance of AMR genes conferred
by phage compared to plasmids (Supplementary Fig. 8b).
Distribution of AMR categories encoded by mobile genetic
elements
Assessing AMR conferred by MGEs, we found that both plasmids
and phages encoded genes conferring resistance to several
classes of antibiotics (Fig. 5c). Though significant differences were
not apparent, we found that phage-encoded AMR genes against
vancomycin (glycopeptide) and numerous other antimicrobials
were dominant in both birth mode groups. In addition, plasmids
conferred resistance to diaminopyrimidine and bacitracin, as well
as β-lactams, phenicol, MLS and tetracyclines (Fig. 5c). Strikingly,
these data suggest that MGE-mediated AMR, encoded by phages,
is a potential factor in conferring AMR or serve as a reservoir for
antimicrobial resistance throughout the first years of life.
Phage-mediated horizontal gene transfer (HGT)
To understand phage-mediated horizontal gene transfer of AMR
we analysed, in detail, phage contigs encoding AMR genes. We
identified several genes that were horizontally transferred within
the CSD and VD groups (Supplementary Data 4 and Supplemen-
tary Fig. 9). CSD samples (n= 3; C112, C113 and C119), exhibited
HGT involving AMR genes including resistance to glycopeptide
and multidrug (Fig. 6a–d). The majority (~88%) mapped to the
bacterial chromosome. However, two genes encoding multidrug
resistance were encoded by both chromosome and phage (C119:
contig 2568, Supplementary Data 4). The contig was found to be a
candidate prophage based on detailed inspection and was found
to encode several genomic regions with prophage signatures
flanking the multidrug resistance genes (Fig. 6f). In addition, the
coverage of the contig across its entire length was more variable
in the genomic regions where the prophage and AMR gene
sequences were identified. Resolution of the taxa involved
indicated HGT between the Intestinimonas butyriciproducens
(GCA 003096335) and Clostridium bolteae (ATCC BAA 613 GCA
000154365) strains belonging to the Oscillospirallales and Lach-
nospirallales orders, respectively (Supplementary Fig. 10).
DISCUSSION
Birth mode is postulated to represent a major factor in shaping
earliest gut microbiome colonisation and the linked development
of neonates especially in relation to the priming of the neonates’
immune system.3 Apart from birth mode, additional aspects such
as diet and medical factors have been described to have a
significant effect on neonate colonisation and succession.19
Whether or not such effects persist during the first year of life
remains an essential question. Here, we performed an in-depth
longitudinal analysis of the gut microbiome using high-resolution
metagenomics on samples collected during the first few days
postpartum through to the first year of age. We specifically
assessed the pervasive effect of birth mode-dependent micro-
biome differences in relation to immune system priming and AMR.
In addition, we analysed the contribution of mobile genetic
elements and the role of horizontal gene transfer in
conferring AMR.
Our previous findings8 along with the longer-term trends of the
present study underpin the notion that persistent structural and
functional differences exist in the gut microbiomes of neonates
born by CSD. More specifically, our results agree with other studies
which have highlighted a reduced abundance and colonisation by
taxa such as Bifidobacterium and Bacteroides in CSD neo-
nates.6,8,24,55,56 In addition, we found that the levels of Faecali-
bacterium prausnitzii were significantly elevated in VD infants after
1 year of age. F. prausnitzii is a highly abundant commensal in the
human gut including those with higher levels of diversity and
richness when compared to individuals following a Western
lifestyle.57 Concurrently, this taxon has been reported to be
reduced in the gut of patients with ulcerative colitis and Crohn’s
disease,58 which in turn may be linked to it being a keystone taxon
conferring anti-inflammatory properties in humans.59,60 Further
studies are necessary to effectively understand the longer-term
consequences of the differential abundance of F. prausnitzii in
humans beyond the first year of age.
Our previously published study8 highlighted a higher potential
for LPS-mediated immune priming in VD compared to CSD at day
5 after birth. Conversely, we found that LPS extracts from the CSD
samples taken at 1 year of age resulted in significantly higher TNF-
α levels compared to 5 days after birth. Our results indicate that a
reduction in the earliest immune system priming through key
immunogenic molecules occurs in CSD neonates. This might lead
to persistent effects throughout the first year of life which, in turn,
may explain the higher rates of immune system-linked diseases
observed in CSD infants in later life including metabolic
disorders11,55 and allergies.12,13 Along these lines, Jakobsson
et al. previously showed that children born via CSD have reduced
Th1 responses.4 Furthermore, other groups have reported that
early-life immune system stimulation impacts immune-disorders
including asthma,61 allergies,62 diabetes and IBD.63 In this context,
our findings indicate that birth mode-dependent gut microbiota
alterations affect the status of the immune system throughout the
first year of life, and likely beyond. This in turn may explain
immunological deficits linked to numerous chronic diseases for
which a higher propensity is observed in individuals born by
CSD.64
Birth mode-associated alterations of the gut microbiota may
facilitate colonisation by opportunistic pathogens, including those
encoding antimicrobial resistance.15 Functional analyses of our
metagenomic data highlighted enrichments in carbapenem and
phenazine biosynthesis genes in the VD group after the first year
of life, potentially a consequence of endogenous gut bacteria-
mediated resistance mechanisms against opportunistic pathogens
in the gut. Both carbapenem and phenazine are known to be
bacterial compounds that are used clinically in fighting Gram-
positive and Gram-negative pathogens.65,66 This data suggests
that the indigenous gut microbiota plays a crucial, early role in
conferring colonisation resistance against pathogens. In addition,
we found that CSD is associated with resistance against semi- and
synthetic antibiotics as early as 5 days after birth. It is well
established that mothers undergoing CSD are administered
antibiotics to prevent nosocomial infections, as a prophylactic
policy.42,67,68 Interestingly, we did not find resistance towards the
antibiotic treatment administered to mothers in our cohort. It,
however, remains plausible that the enrichment in AMR genes
especially against phenicol, pleuromutilin and diaminopyrimidine
classes at day 5 after birth in CSD neonatal samples is linked to the
hospital environment including the actual caesarean section.
In conjunction with the observed differences in AMR between
CSD and VD our study also highlights the potential mode of AMR
transmission via mobile genetic elements including via plasmids
and/or bacteriophages.69–71 Parnanen et al. reported the presence
of AMR genes and MGEs in infant faecal samples at 1 and
6 months of age.72 Our findings agree with their results and
expand on these by additionally providing data on the abundance
of AMR genes and MGEs at 5 days after birth. Furthermore, we
identified 27 categories of AMR genes and linked these to both
bacterial taxonomy and MGEs. We found that both plasmids and
phages encoded genes which confer resistance to several classes
S.B. Busi et al.
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Fig. 6 Horizontal gene transfer (HGT) events. Schematics depicting the a diaminopyrimidine resistance gene transfer between Blautia and
Dorea in sample C112 (CSD). The lighter blue and green arrows represent genes localized on the forward and reverse strands, respectively. Red
bars indicate matching regions between contigs with darker shades representing higher similarity. b HGT event transferring glycopeptide
resistance between Clostridium_P and Clostridium in C113 (CSD). c–e Multidrug resistance genes were transferred horizontally between the
following genera: Intestimonas and Clostridium, Ruminococcus and Roseburia, Enterococcus and Clostridium, in sample C119 (CSD). The timepoints
at which the genomes were recovered and to which the HGT event corresponds are indicated next to the genera nomenclature. f Linear
representation of ‘contig_2568’, which mapped to both bacterial chromosome and phage. Area plot (grey) and dot plot (red) indicating the
coverage of the genomic regions. Triangles (red) indicate the prophage sequences (Supplementary Data 4) and their localisation coordinates
along the contig, while the dark-blue triangle indicates the location of the multidrug AMR genes (n= 2) on the contig.
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of antibiotics. Of all MGEs, plasmids conferred resistance to a
variety of antimicrobial compounds. Furthermore, we found that
glycopeptide and multidrug resistance were transferred via
phages, in accordance with previous reports.73–75 We also found
that horizontal gene transfer plays a critical role in the continued
transmission of AMR during the first year of life. While ~88% of
HGT occurred via canonical methods involving the bacterial
chromosome and plasmids, we found that prophages contributed
to multidrug resistance in one CSD sample (C119). We detected
prophage signature sequences flanking two multidrug resistance
genes, horizontally transferred between bacteria from two distinct
orders. Our findings thereby highlight the role of prophages,
typically thought to mediate AMR in humans pathogens including
Staphylococcus aureus,76 Salmonella and shiga toxin-producing
Escherichia coli,77 as mediators of HGT even among commensals.
Intriguingly, HGT events in the VD samples did not indicate any
AMR gene transmission. On the other hand, considering the
smaller sample size, further studies with an increased power are
needed to clarify the role of phage-mediated AMR resistance
especially during the first few days of life.
The persistence of differences in early-life exposure is an
important but challenging research question, not least because of
the paucity of long-term, longitudinal studies ranging from
immediately after birth until early childhood. Our findings imply
that birth mode leads to persistent gut microbiota structural and
functional differences. We acknowledge that the limited sample
size and the lack of detailed dietary information cannot rule out
other confounding factors such as the in utero and postpartum
environments of the infants. However, and importantly, our data
suggest that gut microbiota structural and functional effects may
predispose infants delivered by CSD to delayed immune priming
resulting in a deficiency in tolerance. Our results pave the way for
future, rational interventions aimed at restoring key functional
features of the microbiota. In this context, further studies
including following the children over extended periods of time
are needed to understand birth mode-mediated manifestations of
disease. Concurrently, an important research direction which
arises from our study centres on the role of the gut mobilome in
conferring AMR and how this affects microbiome trajectories and
linked phenotypic outcomes in humans. Considering current
global efforts directed at limiting the emergence of antibiotic
resistance,78 appreciation of the role of phages as an additional
source of resistance may be necessary for success in reducing the
overall burden of AMR in the future.
METHODS
Ethics statement
All aspects concerning the recruitment and collection of mother-neonate
pairs including handling, processing and storing of samples as well as data
were approved by the Luxembourg Comité national d’éthique de
recherche, under reference number 201110/06 and by the Luxembourg
National Commission for Data Protection under reference number
A005335/R000058. Prior to specimen collection, following a detailed
consultation; written and informed consent was obtained from all mothers
enrolled in the study.
Sample collection
Based on our previous study,8 the present study design aimed at testing
the hypothesis that birth mode elicits longer-term functional microbiome
changes which may impact neonatal health and development (with
particular foci on antimicrobial resistance and lipopolysaccharide biosynth-
esis) and we performed the corresponding power analyses using data from
our previous study. Founded on the increase in fold-change [caesarean
section delivery (CSD) versus vaginal delivery (VD)] in antimicrobial
resistance genes, a sample size calculation revealed a minimum number
of four individual mother–infant pairs per group to achieve a power of 80%
with a significance threshold of 5%. For the LPS-mediated functional
cytokine measurements, we estimated a minimum sample size per group
of six pairs based on a fold-change of 1.40x in TNF-α, i.e., a 40% difference
of means between the samples (Supplementary Fig. 11). As previously
published,8,39 we found that the functional microbiome differences
provide clearer delineations when comparing groups than the typically
reported taxonomic profiles. Based on our hypothesis, we focused on
functional endpoints, in particular on the emergence and acquisition of
AMR genes and the LPS-mediated immune stimulation. As per the results
of the power analyses highlighting a minimum requirement of 6
mother–infant pairs per group, we further inflated the per-group sample
size by 50% leading to a minimum of 9 mother–infant pairs per group. In
the present study, babies delivered via caesarean (CSD, n= 11) and vaginal
(VD, n= 9) deliveries were sampled during the first days of life and were
followed-up at 1 month, 6 months and at 1 year of age (Supplementary
Data 2). Samples were collected during follow-up visits into sterile plastic
vials and immediately flash-frozen in liquid nitrogen. Faecal samples were
stored until further processing at −80 °C.
Faecal processing and nucleic acid extraction
Genomic DNA was isolated from 50mg of frozen stool samples aseptically
weighed into sterile vials, prior to processing with the DNeasy PowerSoil
Kit (Qiagen, Luxembourg) including an additional incubation step at 65 °C
and milling, as described previously.8 All the study samples yielded
sufficient DNA for metagenomic sequencing including artefact-curated
metagenomic data as described previously8 for subsequent analyses. DNA
extracted from all timepoints was thereafter stored at −80 °C until
further use.
DNA sequencing
All DNA samples were subjected to random shotgun sequencing. Briefly,
250 ng of DNA was sheared using Bioruptor NGS (Diagenode, UCD300)
with 30-s ON and 30-s OFF for 15 cycles. The sequencing libraries were
prepared using TruSeq Nano DNA library preparation kit (Illumina, FC-121-
4002) using the protocol provided with the kit. The libraries were prepared
considering 350 bp average insert size. Prepared libraries were quantified
using Qubit (Invitrogen) and the quality was checked on a Bioanalyzer
(Agilient). Sequencing was performed on the NextSeq500 (Illumina)
instrument using 2 × 150 bp read length at the LCSB Sequencing Platform.
Data processing for metagenomics, including genome
reconstruction
Paired forward and reverse sequences were processed using the
metagenomic workflow of the Integrated Meta-omic Pipeline79 (IMP).
The metagenomic processing workflow includes pre-processing, assembly,
genome reconstruction and functional annotation of genes based on
custom databases in reproducible manner. Briefly, the adapter sequences
were trimmed in the pre-processing step including the removal of human
reads. Thereafter the de novo assembly was performed using the MEGAHIT
(version 2.0) assembler.80 Default IMP parameters were retained for all
samples. Subsequently, we used MetaBAT281 and MaxBin282 for binning in
addition to an in-house binning methodology previously described.83 This
involved ignoring ribosomal RNA sequences in kmer profiles, clustering
from VizBin embeddings,84 using density-based non-hierarchical clustering
algorithms and depth of coverage for genome reconstructions. The
reconstructed genomes are hereafter referred to as bins or metagenome-
assembled genomes (MAGs). We obtained a non-redundant set of MAGs
using DASTool85 with a score threshold of 0.7 for downstream analyses.
Metagenomic taxonomic classification, virome and functional
analyses
Trimmed and pre-processed read pairs were used as input to determine
the microbial abundance and population genomic profiles based on the
mOTUs86 (version 2) tool. Based on the marker genes in the mOTU2
database taxonomic profiling was performed. The relative abundances of
the mOTUs were estimated using a minimum alignment length of 125
basepairs (bp), where the read counts were normalized to the gene length
while also accounting for base coverage of the genes. This was done using
the motus profile option with the built-in option (-c) for relative abundance
values per samples. Simultaneously, to improve specificity and minimise
false positives, a cut-off of seven genes that deviated from the median was
used as an additional parameter to improve both sensitivity and precision.
For the reconstructed MAGs, completeness and contamination were
determined using CheckM,87 while the taxonomy for each MAG was
assigned using the GTDB (Genome Taxonomy Database) toolkit (gtdb-tk)50
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using the lineage_wf option and by using the fasta files as inputs for
the MAGs.
For the analyses of functional potential from the assembled contigs,
open-reading frames were predicted from the assembled contigs using a
modified version of Prokka88 that includes Prodigal89 gene predictions for
complete and incomplete open-reading frames. The identified genes were
annotated with a hidden Markov models90 (HMM) approach, trained using
an in-house database84 including all KO,41 TIGRFAM and SWISS-PROT91
groups and using hmmsearch from HMMER 3.1.92 Where multiple
functional groups were assigned to genes, the best hits based on bit
scores were selected. FeatureCounts93 was used to extract the number of
reads per functional category, using the arguments -p and -O, thus yielding
counts for each functional category. After the LPS-cytokine analysis,
insufficient faecal sample for one of the CSD samples (C118) remained for
metagenomic sequencing. Therefore, the sample was removed from
subsequent metagenomic analyses. For the virome analyses, we used an
iterative annotation method to recover microbial (bacterial and archaeal)
viruses,94 and subsequently taxonomically annotated using a network-
based classification protocol defined by Bolduc et al.95 Samples C109 was
not included in the virome analyses due to viral contigs being below
detection confidence thresholds.
Identification of antimicrobial resistance genes and
association with mobile genetic elements
We used a deep-learning approach, DeepARG,43 to predict and identify
AMR genes within our metagenomic data. The output from Prokka, i.e. the
translated fasta sequence files for all open-reading frames, was used as
input for the AMR analyses. AMR genes were collapsed into categories
based on the Comprehensive Antibiotic Resistance Database (CARD)44 and
identified using DeepARG. Thereafter, the relative abundance of the AMR
genes was calculated using the Rnum_Gi method described by Hu et al.96
Identified AMR genes and their categories were consecutively linked to
associated bacterial taxonomy using the metagenomic bin classification.
Furthermore, AMR genes were linked to predicted mobile genetic
elements (MGEs; phages and plasmids) to identify probable transmission
of AMR between taxa. For the identification of plasmids in the
metagenomic data, PlasFlow54 was used with a threshold for filtering set
to 0.7. Simultaneously, DeepVirFinder97 and VirSorter98 were used to
identify phage sequences within the VD and CSD groups. Predictions from
both these tools were subsequently merged to obtain a comprehensive
catalogue of phage sequences. For the prediction of phage sequences, the
DeepVirFinder thresholds for filtering were set at a p-value of < 0.05 and a
score of 0.7, while for VirSorter the category 1 and 2 predictions were used
for downstream analyses. To link both the MGEs and the taxonomy to the
AMR genes, we mapped the genes to assembled contigs, followed by
identifying the corresponding bins (MAGs) to which the contigs belonged.
By considering all different predictions of MGEs, a final classification was
made based on the genomic contexts of the AMR genes encoded on
plasmids, phages or chromosomes, including classification of those that
could not be resolved (ambiguous). Those AMR genes that could not be
assigned to either the MGEs or bacterial chromosomes were further
referred to as unclassified genomic signatures. Certain AMR genes were
encoded on both the bacterial chromosome and phage genomes
(Supplementary Data 4). In such cases, we recorded the encoded AMR
gene as being ambiguous. The confirmation of AMR genes and their
associated mode of transfer was performed manually alongside the
mapping of identical 1 Kbp flanking regions, via the MetaCHIP analyses
pipeline.99 Briefly, groups of genes among all input MAGs with maximum
average identity were considered putative HGT genes. To validate the
predicted candidates, a pairwise BLASTN was used to assess each pair of
flanking regions of 10 Kbp. Visual representations of the genomic regions
were extracted alongside the results for visual interpretation and
inspection. Coverage of the genomic regions was additionally assessed
through the IGV viewer using the bam file, and manually plotted based on
per base coverage statistics for the latter.
LPS isolation and in vitro immunostimulation for cytokine
profiling
From the 1 year of age time point, 150 mg faecal samples were weighed
aseptically and lipopolysaccharide (LPS) was extracted alongside an
extraction blank to serve as a negative control. We also used an in-
house pure culture of E. coli, from which extracted LPS was used as a
positive control. To maximise yields, the samples were divided into
triplicates, i.e. 50 mg per vial, prior to LPS extraction using the hot phenol-
water protocol as previously described.8 After extractions the triplicates
from each sample were pooled and quantified using an endotoxin-
detection assay (Endolisa, #609033, Hyglos GmbH, Germany). All samples
produced sufficient quantities of LPS. The purified LPS was used to
stimulate monocyte-derived dendritic cells (MoDCs). Briefly, primary
human monocytes were derived from blood samples from four healthy
donors obtained through the Luxembourg Red Cross. The monocytes were
further differentiated into MoDCs, in RPMI 1640 medium (ThermoFisher
Scientific) supplemented with 10% foetal bovine serum (ThermoFisher
Scientific), 20 ngml−1 of granulocyte-macrophage colony-stimulating
factor (Peprotech, London, UK), 20 ngml−1 IL-4 (Peprotech) and 1%
penicillin–streptomycin (Invitrogen). Subsequently, the immunostimulatory
potential of the LPS fractions isolated from the 1 year of age faecal samples
was determined. For this, MoDCs were treated with LPS extracts from VD
and CSD samples. The amount of LPS from each sample that was used to
stimulate the MoDCs was adjusted as described by Wampach et al.8 Briefly,
the MoDCs were stimulated with 7.5 µl/well of LPS while a positive control
was established using 15 EU/well LPS isolated from E. coli, and a negative
control was set up by incubating MoDCs with 7.5 µl/well of the LPS
extraction blank. For the in vitro stimulation, the amount of MoDCs was
1 × 105 cells/well. Treatments were performed on cells from all the healthy
donor-derived samples, and analysed for the presence of pro- and anti-
inflammatory cytokines (TNF-α, IL-8, IL-18, IL-1β, IL-12 and IL-10) using both
Human Instant and uncoated ELISA kits (ThermoFisher Scientific).
Data analysis
All figures for the study including visualizations derived from the
taxonomic, functional and cytokine profiling were created using version
3.6 of the R statistical software package.100 DESeq2101 and Wilcoxon rank-
sum tests with FDR-adjustments for multiple testing were used to assess
significant differences for the AMR and taxonomic analyses whereas a
paired two-way ANOVA (analysis of variance) within the nlme package was
used for identifying statistically significant differences in the cytokine
profiles. Volcano plots were generated using the EnhancedVolcano
package.102 Corrplots were generated using the corrgram package
developed for R.103 The metacoder104 package was used to visualize the
AMR-linked taxonomy in R.
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